Literature DB >> 202967

The evidence justifying immunosuppression therapy in multiple sclerosis.

J Mertin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 202967      PMCID: PMC1543529     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  17 in total

1.  Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis.

Authors:  W Sheremata; J B Cosgrove; E H Eylar
Journal:  N Engl J Med       Date:  1974-07-04       Impact factor: 91.245

2.  Evaluation of antithymocyte globulin in acute relapses of multiple sclerosis.

Authors:  T P Seland; T A Mc Pherson; M Grace; G Lamoureux; J G Blain
Journal:  Neurology       Date:  1974-01       Impact factor: 9.910

Review 3.  Multiple sclerosis: an immunologic reassessment.

Authors:  P Y Paterson
Journal:  J Chronic Dis       Date:  1973-03

4.  Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.

Authors:  A S Rose; J W Kuzma; J F Kurtzke; N S Namerow; W A Sibley; W W Tourtellotte
Journal:  Neurology       Date:  1970-05       Impact factor: 9.910

5.  Recurrent experimental allergic encephalomyelitis in the Lewis rat.

Authors:  D E McFarlin; S E Blank; R F Kibler
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

Review 6.  Relevance of fatty acids in multiple sclerosis.

Authors:  J Mertin; C J Meade
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

Review 7.  Immunopathology of demyelination in autoimmune diseases and virus infections.

Authors:  H M Wiśniewski
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

8.  Pilot study with antilymphocyte globulin in the treatment of multiple sclerosis.

Authors:  J Ring; J Seifert; H Anstwurm; E Frick; J Mertin; B Brass; H Backmund; G Lob
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

Review 9.  Laboratory diagnosis of multiple sclerosis: immunological and biochemical aspects.

Authors:  E J Thompson
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

10.  Interaction of HLA molecules with non-immunological ligands as an explanation of HLA and disease associations.

Authors:  A Svejgaard; L P Ryder
Journal:  Lancet       Date:  1976-09-11       Impact factor: 79.321

View more
  2 in total

1.  Immune-cell crosstalk in multiple sclerosis.

Authors:  Richard M Ransohoff
Journal:  Nature       Date:  2018-11       Impact factor: 49.962

2.  Azathioprine in multiple sclerosis--a 3 year controlled study of its effectiveness.

Authors:  U Patzold; P Pocklington
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.